Serum Insulin-Like Growth Factor Binding Protein 7 for Esophagogastric Junction Adenocarcinoma Diagnosis.
作者信息
Zhang Gao-Ming, Zhang Guo-Ming, Zhang Jian-Hua
机构信息
Department of Laboratory Medicine, Shuyang People's Hospital, The Affiliated Shuyang Hospital of Xuzhou Medical University, Shuyang, China.
Jiangsu College of Nursing, Huai'an, China.
出版信息
Gut Liver. 2020 Jul 15;14(4):529. doi: 10.5009/gnl19423.
Abstract
摘要
相似文献
1
Serum Insulin-Like Growth Factor Binding Protein 7 for Esophagogastric Junction Adenocarcinoma Diagnosis.血清胰岛素样生长因子结合蛋白7用于食管胃交界腺癌的诊断
Gut Liver. 2020 Jul 15;14(4):529. doi: 10.5009/gnl19423.
2
Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.血清胰岛素样生长因子结合蛋白 7 作为诊断和预测食管胃结合部腺癌的潜在生物标志物。
Gut Liver. 2020 Nov 15;14(6):727-734. doi: 10.5009/gnl19135.
3
[Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].[UICC-AJCC第7版食管癌和胃癌TNM分期系统对食管胃交界腺癌（SiewertⅡ型）预后预测价值的评估]
Zhonghua Zhong Liu Za Zhi. 2014 Dec 23;36(12):916-21. doi: 10.3760/cma.j.issn.0253-3766.2014.12.008.
4
What is adenocarcinoma of the esophagogastric junction?什么是食管胃交界腺癌？
Am J Gastroenterol. 2008 Feb;103(2):492-3. doi: 10.1111/j.1572-0241.2007.01646_13.x.
5
[Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].[食管癌及食管胃交界腺癌的治疗前错误分类：可能性及临床后果]
Chirurg. 2020 Jan;91(1):41-50. doi: 10.1007/s00104-019-1011-4.
6
Endoscopic detection of superficial esophagogastric junction adenocarcinoma.内镜下检测浅表性食管胃交界腺癌。
Dig Endosc. 2017 Apr;29 Suppl 2:37-38. doi: 10.1111/den.12835.
7
Esophagogastric junction carcinoma: introduction.食管胃交界部癌：引言
Semin Radiat Oncol. 2013 Jan;23(1):1-2. doi: 10.1016/j.semradonc.2012.09.007.
8
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.糖类抗原19-9是食管胃交界腺癌中一种有用的预后标志物。
Cancer Med. 2015 Nov;4(11):1659-66. doi: 10.1002/cam4.514. Epub 2015 Aug 26.
9
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.成纤维细胞生长因子受体2的表达而非其基因扩增，与食管胃交界腺癌的肿瘤生长及较差的生存率相关。
Oncotarget. 2016 Apr 12;7(15):19748-61. doi: 10.18632/oncotarget.7782.
10
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.膜联蛋白A1在食管及食管胃交界腺癌中的表达：与不良预后的关联
Clin Cancer Res. 2006 Aug 1;12(15):4598-604. doi: 10.1158/1078-0432.CCR-06-0483.
本文引用的文献
1
Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.血清胰岛素样生长因子结合蛋白 7 作为诊断和预测食管胃结合部腺癌的潜在生物标志物。
Gut Liver. 2020 Nov 15;14(6):727-734. doi: 10.5009/gnl19135.
2
Serum transforming growth factor beta1 level for knee osteoarthritis diagnosis.用于膝骨关节炎诊断的血清转化生长因子β1水平
Clin Chim Acta. 2017 Nov;474:136. doi: 10.1016/j.cca.2017.09.017. Epub 2017 Sep 22.
Zotero 插件